Related Experiment Video

Updated: Oct 17, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

Mutations in the HIV-1 3'-Polypurine Tract Can Confer Dolutegravir Resistance

José G Dekker1, Bep Klaver1, Ben Berkhout1

  • 1Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdamgrid.7177.6, Amsterdam, The Netherlands.

Antimicrobial Agents and Chemotherapy
|October 11, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
antiretroviral resistancedolutegravirhuman immunodeficiency virus

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.8K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.3K

Related Experiment Videos

Last Updated: Oct 17, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.8K
Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.3K

Related Concept Videos

Viral Mutations00:36

Viral Mutations

35.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
35.1K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.7K

Articles linked to this work by shared authors, journal, and citation graph.

HIV-2 evades restriction by ZAP through adaptations in the U3 LTR region despite increased CpG levels.

Nucleic acids research·2025

Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage.

Molecular therapy. Nucleic acids·2024

CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA.

Journal of virology·2023

HIV-1 3'-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR Circles.

Journal of virology·2023

HIV co-opts a cellular antiviral mechanism, activation of stress kinase PKR by its RNA, to enable splicing of rev/tat mRNA.

Cell & bioscience·2023

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.

Journal of virology·2022

Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.

Antimicrobial agents and chemotherapy·2026

Repeated emergence and fitness heterogeneity of KPC-33 in ST11 Klebsiella pneumoniae under ceftazidime-avibactam pressure.

Antimicrobial agents and chemotherapy·2026

Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.

Antimicrobial agents and chemotherapy·2026

Comparative effectiveness of ceftolozane/tazobactam relative to ceftazidime/avibactam for the treatment of adult, hospitalized patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa in U.S. Veterans Health Administration facilities.

Antimicrobial agents and chemotherapy·2026

A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle.

Antimicrobial agents and chemotherapy·2026

Functional validation of the Plasmodium falciparum K13 C580Y mutation in recently collected Ethiopian isolates.

Antimicrobial agents and chemotherapy·2026

Baseline comorbidity assessment may authorize early steroid-sparing therapy in older patients with polymyalgia rheumatica.

Clinical rheumatology·2026

Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning.

Naunyn-Schmiedeberg's archives of pharmacology·2026

AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.

Journal of medicinal chemistry·2026

Development and psychometric validation of the pharmacogenetic Knowledge, attitudes, and Awareness scale (P-KAAS): an initial validation study in undergraduate nursing students.

Pharmacogenomics·2026

Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study).

Frontiers in clinical diabetes and healthcare·2026

Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.

Journal of diabetes and metabolic disorders·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us